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1. Introduction   
The detection of oligoclonal IgG bands (OCB) in paired serum and cerebrospinal fluid (CSF) samples is still considered 
a valid diagnostic tool in the differential diagnosis of inflammatory diseases of the central nervous system (CNS), 
notwithstanding the OCB ‘downgrading’ by the latest revision of the diagnostic criteria for multiple sclerosis (MS) 
(reviewed in [1]). Two important consensus papers defined the most common OCB patterns that help clinical 
pathologists and neurologists to interpret the results of serum and CSF analysis with the recommended isoelectric 
focusing (IEF) techniques [2, 3]. However, additional IEF patterns, which have not been addressed by the leading 
consensus papers [2, 3], can be detected in routine diagnostics [1]. In particular, the finding of a single IgG band in the 
CSF falls into a grey area between ‘no bands’ (normality) and ‘two bands’ (pathological production of oligoclonal IgG 
within the CNS). A few studies explored this grey area, and found that single CSF IgG bands associated with various 
diseases including CNS infections, lymphomas, demyelinating/autoimmune/paraneoplastic diseases, peripheral nervous 
system (PNS) diseases, and, above all, MS, with a highly variable frequency (from 0 to 44 %) [4–10]. Notably, these 
studies are not fully comparable, due to the use of agarose electrophoresis, on which a single band corresponds to an 
underlying single plasma cell clone, or of IEF, on which a monoclonal gammopathy yields 2-10 bands because of the 
technique’s high resolving power that allows the detection of IgG microheterogeneity [1–3]. In addition to this 
methodological heterogeneity, since only a small number of case series have been studied so far, the frequency and 
diagnostic meaning of single CSF IgG bands is still an open question [1]. 
In our multicenter retrospective study on single CSF IgG bands we aimed to assess: a) their frequency and disease 
associations, b) possible differences in the demographic and other CSF features between the expectedly highly 
represented cohort of MS patients and patients with other diseases, and c) the evolution over time of CSF IEF patterns 
in a subgroup of patients who underwent follow-up spinal taps. 
 
2. Patients and Methods    
2.1 Patients 
Seven Italian neurological centres (Modena, Genoa, Cagliari, Carpi, Piacenza, Verona and Perugia) participated in this 
retrospective study. Patients showing a single CSF IgG band associated with identical bands in CSF and serum (‘mirror 
pattern’) (Figure, a), or alone (Figure, b) between January 2005 and June 2016 were selected from the centres’ 
databases. A single CSF IgG band within a mirror pattern was considered as if it was emerging from a polyclonal 
background, given that a mirror pattern is the product of a purely systemic oligoclonal B-cell activation, without 
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intrathecal IgG synthesis [2, 3]. All the CSF analyses were carried out for diagnostic purposes. The study was approved 
by the Modena Ethics Committee (protocol n. 188/15). 
 
2.2 Demographic and CSF features 
The following variables were collected: sex, age, date and rationale of CSF analysis (symptoms, diagnosis or suspected 
diagnosis), final confirmed diagnosis (if available), date of final confirmed diagnosis. CSF features included: CSF cell 
number and type, concentration of CSF total proteins, CSF/serum glucose ratio, IgG Index, CSF/serum albumin ratio, 
presence or absence of a ‘mirror pattern’ [2, 3].  
2.3 CSF data sources and methods  
Over 92% of the tested serum and CSF samples were analyzed in the three large laboratories of Modena (55%), Genoa 
(22%), and Cagliari (15%), with home-made agarose gel-based IEF techniques (Agarose IEF, Pharmalyte pH 3-10 and 
Pharmalyte pH 8-10.5 GE Healthcare), and a very similar protocol. Briefly, electrode strips were soaked with 0.05 or 
1M sodium hydroxide (catholyte), and 0.05 or 1M sulphuric acid (anolyte). After focusing, the proteins were transferred 
to polyvinylidene difluoride (Modena), or nitrocellulose (Genoa and Cagliari) membranes, which were incubated with 
polyclonal rabbit anti-human IgG (Modena: Dako) or goat anti-human IgG (Genoa: DiaSorin; Cagliari: Sigma-Pierce), 
and then with alkaline phosphatase- (Modena) or peroxidase- (Genoa and Cagliari) conjugated polyclonal swine anti-
rabbit (Modena: Dako) or rabbit anti-goat (Genoa and Cagliari: Dako) IgG. Membranes were finally stained with 5-
Bromo-4-chloro-3-indolyl-phosphate and Nitro blue tetrazolium (Modena: Sigma-Aldrich), or with 3-Amino-9-
ethylcarbazole (Genoa and Cagliari: Sigma-Aldrich). Focusing was performed on a Multiphor II apparatus (GE 
Healthcare) in all centres. All the other samples were analyzed in the laboratories of Verona (which used IsoGel 
Agarose IEF pH 3-10 Lonza, 1M sodium hydroxide and 0.5M carboxylic acid, polyclonal rabbit anti-human IgG-Dako, 
biotinylated anti-rabbit IgG-Vectastain ABC kit and 3-Amino-9-ethylcarbazole) and Perugia (which used Hydragel 9 
CSF isofocusing kit-Sebia). 
Since 2000 the laboratories have been participating in external quality control schemes, annually organized by the 
Italian Association of Neuroimmunology (AINI). These schemes show that the analytical quality of OCB detection and 
the between-center agreement on the results of the external quality controls have substantially improved over the years 
(D. Fr., personal communication). As a proof of principle, the Laboratory of Neuroimmunology of Pavia, which is part 
of the AINI network, received 15 pairs of serum and CSF samples, with or without a single CSF IgG band, from the 
center of Modena, and blindly tested them, with a resulting strength of agreement that is considered to be 'fair' (k=0.25). 
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This result is in line, if not better than expected, with the fact that the IEF technique has low inter-laboratory 
reproducibility, mainly due to the non-linearity of the pH gradient, and to the so called ‘cathodic drift’[1] and that 
‘critical’ CSF samples, e.g., those with single CSF IgG bands, are at a high risk of misinterpretation (reviewed in [1]).  
As for the IEF track interpretation, the centers of Genoa and Modena exchanged and blindly assessed pictures of paired 
CSF and serum samples of 112 patients. A single IgG band was concordantly identified in 91% of cases (kappa of 
agreement, 0.82). Furthermore, the center of Modena re-tested 15 CSF and serum samples showing a single CSF IgG 
band, with completely matching results. 
2.4 Statistical methods 
Absolute frequencies and percentages were calculated for categorical variables and the mean (± standard deviation) 
and/or the median (± interquartile range) for continuous variables. Comparisons between groups were made using the 
Kruskal-Wallis test for continuous variables and Fisher’s exact test for categorical variables, followed by post-hoc tests. 
3. Results  
3.1 Diagnoses  
Out of a total of 9422 CSF analysis reports, 151 showed a single CSF-restricted IgG band (1.6%). A definite diagnosis 
was available in 129/151 patients (Table 1). MS was the single disease with the highest frequency of single IgG band 
detection. Cumulatively, MS and CNS inflammatory-demyelinating diseases (clinically isolated syndrome, 
radiologically isolated syndrome and neuromyelitis optica spectrum disorder) accounted for 46.5% of all the cases 
(Table 1). 
3.2 Intra- and between-group comparisons  
Twenty-eight of the patients with a single CSF IgG band were diagnosed with MS, 32 with CNS inflammatory-
demyelinating diseases and 69 with miscellaneous diseases. Mean age in patients with MS and in patients with CNS 
inflammatory-demyelinating diseases was significantly lower than in patients with all the other diseases.  Patients with 
MS or with CNS inflammatory-demyelinating diseases had a lower frequency of single CSF IgG bands associated with 
a mirror pattern in comparison with patients with miscellaneous diseases (Table 2).. 
3.3 Follow-up findings 
Ten patients underwent a second spinal tap after a mean interval of 458 days (range: 22-1482) from the first one. Three 
patients (one with MS, one with progressive multifocal leukoencephalopathy and one with cerebral lymphoma) 
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developed an oligoclonal pattern, while four patients (one with a compressive myelopathy, one with neurosarcoidosis, 
one with  motor neuron disease and one with anti- N-methyl D-aspartate receptor antibody encephalitis - following 
treatment and remission) lost the single CSF IgG band, which remained unchanged in three patients with myelitis, viral 
encephalitis or neuro- systemic lupus erythematosus. 
4. Discussion 
Our main finding indicates that single CSF IgG bands preferentially associate with inflammatory diseases of the CNS. 
Indeed, nearly one half of the cases were found in patients with MS or inflammatory-demyelinating CNS diseases in, 
and another 12% in patients with CNS infections or autoimmune/paraneoplastic neurological diseases. A clear-cut and 
mature CNS-restricted oligoclonal B-cell response is expected in all these disorders (reviewed in [1]). It is thus likely 
that single CSF IgG bands might be the ‘tip of the iceberg’ of oligoclonal responses that are either mounting, or weak in 
nature, if lumbar puncture is performed near to the onset of the disorder. The abnormality could, therefore, indicate a 
‘possible’ intrathecal IgG synthesis [6]. 
As for the mean younger age found in patients with MS or CNS inflammatory-demyelinating diseases  versus all other 
patients, this finding likely depends on the typically younger age of MS onset. Analogously, the association between 
single CSF IgG bands and a mirror pattern was more frequent in non-MS pathologies, probably because in the latter 
conditions, including infectious disorders, a mirror pattern, which reflects a systemic B-cell activation, can be relatively 
common [1].  
Table 3 summarizes the main findings of other studies exploring the diagnostic significance of a single IgG band. 
Cumulatively, these findings confirm our data on the preferential association between single CSF IgG bands and CNS 
inflammatory disorders. The plausibility of such an association is reinforced by the fact that 3 of 10 of our patients with 
repeated lumbar punctures developed OCB (one case of conversion from Clinically Isolated Syndrome to MS), which is 
in line with the data of the only other follow-up study on the topic [5]. The study showed that 33% of the patients with a 
single CSF IgG band later manifested CSF OCB (two thirds of them had inflammatory demyelinating diseases), 
whereas in approximately 50% of them the pattern remained unchanged [5]. 
The transition from single CSF IgG band patterns to full-blown OCB patterns in MS is not surprising, as many studies 
have shown intra-patient variations of OCB patterns in this disease over time [11–13], with a high number of intrathecal 
B-cell clones in patients with the longest disease duration [12] . 
In very rare cases, single CSF bands can be expected in cerebral lymphomas [5, 8, 14]. In the present series too, there is 
a patient with a cerebral marginal zone lymphoma. Four additional patients had hematopoietic malignancies 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
(lymphomas in 3 and chronic lymphocytic leukemia in one patient). Although reported in one case [15], single CSF 
bands in such systemic disorders seem to be incidental rather than disease-related. 
On the other hand, the present and the previous studies [4, 5, 7] show that in about one third (17-44%) of patients with 
single CSF IgG bands, the associated diseases are either vascular or degenerative in nature, or they affect the PNS. An 
intrathecal IgG production is, therefore, unexpected.  
In these cases, it is likely that finding a single CSF IgG band might derive from misinterpretations of the IEF tracks in a 
few cases at least, due to the artifactual banding that is typical of IEF, and as suggested by the results of the AINI 
external quality control schemes [1]. In the IEF-OCB field, some degree of inter-laboratory variability is more than 
expected (but no study has ever addressed this issue), as IEF is a technique that is inherently quite impossible to 
standardize. This shortcoming is an objective and insoluble limit of any multicenter study on the topic, including the 
present one. Both the inclusion of single CSF IgG band false positive cases, and the exclusion of false negative ones can 
thus have affected the study findings. However, the fact that the results did not differ substantially from those of the 
previously published studies [4–10], suggests that the rate of incorrect IEF track interpretation might be acceptable. 
Moreover, the three laboratories that examined more than 90% of paired serum and CSF samples participate in the AINI 
external quality control schemes, and some procedures aimed at boosting the reliability of the study have been 
performed.  
As for all the other diseases, 5% of single CSF IgG bands were detected in patients with inflammatory PNS diseases, in 
line, again, with the other studies on the topic (Table 3). In this case, it is difficult to ascribe the abnormality to a weak 
or emerging intrathecal IgG production, as in the case of MS. Indeed, data that favour the hypothesis of a CNS-
restricted intrathecal B-cell activation to intrathecal portions of peripheral nerves [5], or to PNS-CNS shared 
autoantigens [16] have not yet been substantiated by the evidence of full-blown CSF OCB. The very high frequency of 
a CSF-restricted monoclonal IgG band reported by Dalakas and Colleagues in 14/15 patients with chronic relapsing 
polyneuropathy [17] has never been confirmed.   
CSF OCB have been described with very low frequencies in neurovascular [10, 18, 19] and in neurodegenerative [10, 
20] diseases, but, as in the case of patients with headache or psychiatric disorders, single CSF IgG bands are more likely 
traces of previous contacts between infectious agents and the immune system (immunologic memory) than 
abnormalities related to ongoing intrathecal B-cell activation. 
5. Conclusion 
Our data show that the single most frequent diagnosis in patients with a single CSF-restricted IgG band is MS, followed 
by diagnoses of inflammatory disorders of the CNS. Overall, these findings indicate that single CSF IgG bands tend to 
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associate with diseases characterized by an involvement of intrathecal humoral immune responses, and strongly support 
the notion that this abnormality should alert clinical pathologists and neurologists of a possible presence of 
inflammatory disorders of the CNS.  Given such an important diagnostic weight, although rare, single CSF IgG bands 
should always be reported, and in uncertain clinical cases, the lumbar puncture should be repeated after 6-12 months. 
Figure Legend 
Figure Examples of isoelectric focusing patterns characterized by a single CSF IgG band associated with identical 
bands in CSF and serum (‘mirror pattern’) (a), or alone (b)    
CSF: cerebrospinal fluid; S: serum; : anode; : cathode 
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Table 1. Diagnoses associated with a single CSF IgG band in our cohort of 129 patients 
Diagnosis Number of 
patients (%) 
Multiple Sclerosis 28 (21.7%) 
CNS inflammatory-demyelinating diseases1 32 (24.8%) 
CNS infections2 9 (7%) 
Tumours3  8 (6.2%) 
Inflammatory PNS diseases4 7 (5.4%) 
CNS autoimmune/paraneoplastic neurological diseases5 6 (4.7%) 
Miscellaneous diagnoses6 39 (30.2%) 
 
1clinically isolated syndrome, radiologically isolated syndrome and neuromyelitis optica spectrum disorder  ; 
2Borrelia burgdorferi, Herpes simplex virus, John Cunningham virus, treponema pallidum; 3tumours 
within/adjacent to the CNS: cerebral marginal zone lymphoma, cerebral glioma, dysembryoplastic neuroepithelial 
tumour, vertebral metastasis; hematologic tumours: chronic lymphocytic leukemia, Non-Hodgkin lymphoma, 
hepatic-pulmonary lymphoma; 4Guillain-Barrè syndrome, anti-MAG neuropathy, multifocal motor neuropathy, 
chronic inflammatory demyelinating polyneuropathy; 5neuro-systemic lupus erithematosus, Bickerstaff 
encephalitis, anti-phospholipid syndrome, cerebral vasculitis, anti- N-methyl D-aspartate receptor antibody 
encephalitis; 6idiopathic intracranial hypertension, spondilomyelopathy, cerebral ischaemia, vascular 
encephalopathy, amyotrophic lateral sclerosis, polyneuropathy, Alzheimer’s disease, fronto-temporal dementia, 
neurosarcoidosis, Tolosa-Hunt syndrome, cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy, Melkersson-Rosenthal syndrome, reversible cerebral vasoconstriction syndrome, HCV-
related multineuropathy, DYT1-positive dystonia, cerebral venous thrombosis, migraine, tension-type headache, 
syndrome of transient headache and neurologic deficits with cerebrospinal fluid lymphocytosis, spinal dural fistula,  
psychiatric conditions (catatonia, conversion disorder), post-traumatic epilepsy, perinatal paraparesis, transient 
global amnesia 
 
Table
Table 2 Demographic and cerebrospinal fluid characteristics of patients with a single cerebrospinal fluid IgG 
band with multiple sclerosis, CNS inflammatory-demyelinating and miscellaneous diseases 
 Multiple 
sclerosis 
(n=28) 
CNS inflammatory-
demyelinating 
diseases 
(n=32) 
Miscellaneous 
diseases 
(n=69) 
p-value 
Age (years) (mean ± SD)  37.7± 13 37.2± 15 50.3± 19  *0.003 
Sex (Male/Female)  13/15 10/22 27/42 ns 
CSF cell count (number/μl),  
median (IQR) 
3 (1-7) 1.5 (1-3.5) 1 (1-2) ns 
CSF total protein (g/dl), 
median (IQR) 
47 (27-59) 37 (33-49) 37 (30-48) ns 
IgG index, median  (IQR) 0.53 (0.5-0.65) 0.56 (0.5-0.6) 0.58 (0.5-0.66) ns 
CSF/serum albumin,  
median (IQR) 
5 (3.1-6.7) 4.7 (3.6-6.3) 4.6 (3.7-6.3) ns 
Additional mirror pattern 
(yes/no)  
2/26 3/29 17/49 ∞0.04 
 
SD= standard deviation; IQR= interquartile range 
*post-hoc tests: MS versus CNS inflammatory-demyelinating diseases: p=0.45; CNS inflammatory-demyelinating 
diseases versus miscellaneous diseases: p=0.0003; MS versus miscellaneous diseases: p=0.001 
∞ post-hoc tests: MS versus CNS inflammatory-demyelinating diseases: p= 0.6; CNS inflammatory-demyelinating 
diseases versus miscellaneous diseases: p= 0.048; MS versus miscellaneous diseases: p=0.032 
 
Table
Table 3. Studies exploring the frequency and diagnostic meaning of single cerebrospinal fluid-restricted IgG 
bands 
Authors N/total (%) 
MS 
N (%) 
CNS 
inflammatory
/ 
autoimmune/ 
paraneoplasti
c disease 
N (%) 
PNS 
inflammato
ry disease 
N (%) 
CNS 
infection 
N (%) 
CNS tumor 
N (%) 
Seemingly 
unrelated 
disease 
N (%) 
McCombe et al 
[8] 
3/1490 
(0.2%) 
- 1 (33) 1 (33) - 
1 (33) 
(lymphoma) 
- 
Ben-Hur et al [4] 
33/6000 
(0.6%) 
(20 with 
diagnosis) 
7 (35) 9 (45) 
3 (15) 
(1 had MS 
too) 
- - 
2 (10)1 
 
Franciotta et al 
[7] 
61/3273 
(1.9%) 
27 (44) 
8 (13) 
 
1 (2) 16 (26) - 
9 (15)2 
 
Davies et al [5] 
31 
(27 with 
diagnosis) 
3 (11) 
 
7 (26) - 4 (15) 
1 (4) 
(lymphoma) 
12 (44)3 
 
N= number; 1 torsion dystonia, superficial hemosiderosis of the CNS; 2polyneuropathy (n=5),Alzheimer’s disease 
(n=2), retrobulbar optic neuropathy (n=2); 3axonal neuropathy (n=2), vascular disease (n=2), other/no diagnosis (n=8): 
orthostatic tremor, migraine+/-, oscillopsia, intermittent sensory symptoms, cerebral venous infarction, progressive 
cerebellar syndrome, chronic myalgia 
 
Table
